The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
<h4>Background</h4>Trastuzumab is a valuable therapy option for women with ERBB2(HER2)+ breast cancer tumours, often used in combination with chemotherapy and alongside other therapies. It is known to have adverse effects, but these have proved difficult to separate from the effects of o...
Main Authors: | Christopher Jackson, Leila Finikarides, Alexandra L J Freeman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0275321 |
Similar Items
-
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis
by: Christopher Jackson, et al.
Published: (2022-01-01) -
PIGGY BACK SEPARATOR DESIGN
by: Néhémie Bikayi Tshiani, et al.
Published: (2023-06-01) -
The Hedge Fund Game: Incentives, Excess Returns, and Piggy-Backing.
by: Foster, D, et al.
Published: (2008) -
Semantic Reconstruction of Piggy Backers, Qualitative Study of Informal Piggy Backers in Saqez.
by: kaveh salimi, et al.
Published: (2020-05-01) -
Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
by: Ye Yuan, et al.
Published: (2022-12-01)